MENU
+Compare
SCLX
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$19.94
Change
+$1.19 (+6.35%)
Capitalization
122.18M

SCLX Scilex Holding Company Forecast, Technical & Fundamental Analysis

Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain... Show more

SCLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SCLX with price predictions
Nov 28, 2025

SCLX in -10.04% downward trend, falling for three consecutive days on November 25, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where SCLX declined for three days, in of 220 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

SCLX broke above its upper Bollinger Band on November 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 45 cases where SCLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on SCLX as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SCLX just turned positive on November 20, 2025. Looking at past instances where SCLX's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

SCLX moved above its 50-day moving average on November 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SCLX crossed bullishly above the 50-day moving average on November 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SCLX advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 200 cases where SCLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SCLX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (8.915). SCLX has a moderately low P/E Ratio (0.000) as compared to the industry average of (23.825). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.041). SCLX's Dividend Yield (0.000) is considerably lower than the industry average of (0.026). P/S Ratio (4.263) is also within normal values, averaging (3.624).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SCLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

View a ticker or compare two or three
SCLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
960 San Antonio Road
Phone
+1 650 516-4310
Employees
105
Web
https://www.scilexholding.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMZNF0.39N/A
N/A
QORIA LTD.
IHICF20.25N/A
N/A
IHI Corp
VICP1.50N/A
N/A
Vicapsys Life Sciences, Inc.
CLGCF0.05N/A
N/A
Clarity Metals Corp.
SSSAF35.00N/A
N/A
SHURGARD SELF STORAGE LTD.

SCLX and Stocks

Correlation & Price change

A.I.dvisor tells us that SCLX and BIIB have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SCLX and BIIB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCLX
1D Price
Change %
SCLX100%
-3.49%
BIIB - SCLX
20%
Poorly correlated
+1.51%
AMRN - SCLX
20%
Poorly correlated
-0.38%
SNY - SCLX
9%
Poorly correlated
-0.22%
ABBV - SCLX
8%
Poorly correlated
-0.32%
RHHVF - SCLX
8%
Poorly correlated
N/A
More